Skip to main content
Grant Details

Grant Number: 5R01CA114467-05 Interpret this number
Primary Investigator: Ulrich, Cornelia
Organization: Fred Hutchinson Cancer Research Center
Project Title: Prostaglandin Synthesis, Genetics and Colorectal Cancer
Fiscal Year: 2010
Back to top


Abstract

Aspirin and other non-steroidal inflammatory drugs (NSAIDs) appear to be effective chemopreventive agents against colorectal carcinogenesis. The recognized NSAID targets are cyclooxygenase-1 and -2 (COX1 and 2, or PTGS1 and 2), key enzymes in conversion of arachidonate to prostaglandin (PG) signaling molecules. This interdisciplinary study will evaluate the association between colon and rectal cancer and genetic variability in enzymes and receptors linked to the synthesis of prostaglandins and related arachidonate metabolites. We have identified polymorphisms and haplotypes in key proteins in these pathways. Target proteins include PTGS1 and 2, the thromboxane, prostacyclin, PGD2 and PGE2 synthases, the 5, 12- and 15- lipoxygenases (ALOX5, ALOX12 and ALOX15), PGE2 receptors, and glutathione peroxidases. We will genotype two existing case-control study populations comprising 1676 colon cancer cases with 2004 controls and 827 rectal cancer cases with 1031 controls. Participants were recruited as part of two multi-center, population-based case-control studies in which information on health status, family history, dietary factors (including intakes of n-6 and n-3 fatty acids), physical activity, and NSAID use has been obtained. We propose to use a study design that maximizes available information regarding genetic variability in these key pathways by examining gene-wide haplotypes for sequenced genes (e.g., PTGS1, PTGS2, ALOX12, ALOX15, PGE2 synthase and PGE2 receptors), and a candidate-polymorphism approach for variants with supporting evidence for functional impact. Interactions with NSAID use and dietary fatty acid intakes will be investigated to determine responses of genetically defined subgroups. Using biochemical assays, we will also establish the enzymatic and pharmacological impact of polymorphisms in several key proteins. This biochemical information will be used to inform the genotyping results and the statistical analysis. Results from this collaborative study will provide a powerful test of the role of genetic variability in prostaglandin or eicosanoid synthesis in colorectal carcinogenesis and chemoprevention. They will also advance tailoring of chemoprevention in a way that maximizes benefit and minimizes toxicity.

Back to top


Publications

Implications of Epigenetic Drift in Colorectal Neoplasia.
Authors: Luebeck G.E. , Hazelton W.D. , Curtius K. , Maden S.K. , Yu M. , Carter K.T. , Burke W. , Lampe P.D. , Li C.I. , Ulrich C.M. , et al. .
Source: Cancer research, 2019-02-01; 79(3), p. 495-504.
EPub date: 2018-10-05.
PMID: 30291105
Related Citations

Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer.
Authors: Yuan Z. , Baker K. , Redman M.W. , Wang L. , Adams S.V. , Yu M. , Dickinson B. , Makar K. , Ulrich N. , Böhm J. , et al. .
Source: British journal of cancer, 2017-10-10; 117(8), p. 1202-1210.
EPub date: 2017-08-15.
PMID: 28809863
Related Citations

Genetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family Registry.
Authors: Resler A.J. , Makar K.W. , Heath L. , Whitton J. , Potter J.D. , Poole E.M. , Habermann N. , Scherer D. , Duggan D. , Wang H. , et al. .
Source: Carcinogenesis, 2014 Sep; 35(9), p. 2121-6.
EPub date: 2014-06-07.
PMID: 24908683
Related Citations

Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry.
Authors: Scherer D. , Koepl L.M. , Poole E.M. , Balavarca Y. , Xiao L. , Baron J.A. , Hsu L. , Coghill A.E. , Campbell P.T. , Kleinstein S.E. , et al. .
Source: Genes, chromosomes & cancer, 2014 Jul; 53(7), p. 568-78.
EPub date: 2014-03-28.
PMID: 24677636
Related Citations

COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.
Authors: Makar K.W. , Poole E.M. , Resler A.J. , Seufert B. , Curtin K. , Kleinstein S.E. , Duggan D. , Kulmacz R.J. , Hsu L. , Whitton J. , et al. .
Source: Cancer causes & control : CCC, 2013 Dec; 24(12), p. 2059-75.
PMID: 24022467
Related Citations

Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study.
Authors: Kraus S. , Hummler S. , Toriola A.T. , Poole E.M. , Scherer D. , Kotzmann J. , Makar K.W. , Kazanov D. , Galazan L. , Naumov I. , et al. .
Source: Pharmacogenetics and genomics, 2013 Aug; 23(8), p. 428-437.
PMID: 23778325
Related Citations

Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia.
Authors: Kleinstein S.E. , Heath L. , Makar K.W. , Poole E.M. , Seufert B.L. , Slattery M.L. , Xiao L. , Duggan D.J. , Hsu L. , Curtin K. , et al. .
Source: Genes, chromosomes & cancer, 2013 May; 52(5), p. 437-49.
EPub date: 2013-02-12.
PMID: 23404351
Related Citations

Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia.
Authors: Abbenhardt C. , Poole E.M. , Kulmacz R.J. , Xiao L. , Curtin K. , Galbraith R.L. , Duggan D. , Hsu L. , Makar K.W. , Caan B.J. , et al. .
Source: International journal of molecular epidemiology and genetics, 2013; 4(3), p. 140-9.
EPub date: 2013-09-12.
PMID: 24046806
Related Citations

Functional analysis of human thromboxane synthase polymorphic variants.
Authors: Chen C.Y. , Poole E.M. , Ulrich C.M. , Kulmacz R.J. , Wang L.H. .
Source: Pharmacogenetics and genomics, 2012 Sep; 22(9), p. 653-8.
PMID: 22735388
Related Citations

Decreased cyclooxygenase inhibition by aspirin in polymorphic variants of human prostaglandin H synthase-1.
Authors: Liu W. , Poole E.M. , Ulrich C.M. , Kulmacz R.J. .
Source: Pharmacogenetics and genomics, 2012 Jul; 22(7), p. 525-37.
PMID: 22513397
Related Citations

Glutathione peroxidase tagSNPs: associations with rectal cancer but not with colon cancer.
Authors: Haug U. , Poole E.M. , Xiao L. , Curtin K. , Duggan D. , Hsu L. , Makar K.W. , Peters U. , Kulmacz R.J. , Potter J.D. , et al. .
Source: Genes, chromosomes & cancer, 2012 Jun; 51(6), p. 598-605.
EPub date: 2012-02-27.
PMID: 22371331
Related Citations

Genetic variability in IL23R and risk of colorectal adenoma and colorectal cancer.
Authors: Poole E.M. , Curtin K. , Hsu L. , Duggan D.J. , Makar K.W. , Xiao L. , Carlson C.S. , Caan B.J. , Potter J.D. , Slattery M.L. , et al. .
Source: Cancer epidemiology, 2012 Apr; 36(2), p. e104-10.
EPub date: 2011-12-06.
PMID: 22154103
Related Citations

Polymorphic human prostaglandin H synthase-2 proteins and their interactions with cyclooxygenase substrates and inhibitors.
Authors: Liu W. , Poole E.M. , Ulrich C.M. , Kulmacz R.J. .
Source: The pharmacogenomics journal, 2011 Oct; 11(5), p. 337-47.
EPub date: 2010-06-15.
PMID: 20548327
Related Citations

Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival.
Authors: Slattery M.L. , Curtin K. , Poole E.M. , Duggan D.J. , Samowitz W.S. , Peters U. , Caan B.J. , Potter J.D. , Ulrich C.M. .
Source: International journal of cancer, 2011-06-01; 128(11), p. 2726-34.
EPub date: 2010-11-28.
PMID: 20949557
Related Citations

Genetic variability in EGFR, Src and HER2 and risk of colorectal adenoma and cancer.
Authors: Poole E.M. , Curtin K. , Hsu L. , Kulmacz R.J. , Duggan D.J. , Makar K.W. , Xiao L. , Carlson C.S. , Slattery M.L. , Caan B.J. , et al. .
Source: International journal of molecular epidemiology and genetics, 2011; 2(4), p. 300-15.
EPub date: 2011-12-03.
PMID: 22199994
Related Citations

Polymorphisms in WNT6 and WNT10A and colorectal adenoma risk.
Authors: Galbraith R.L. , Poole E.M. , Duggan D. , Muehling J. , Hsu L. , Makar K. , Xiao L. , Potter J.D. , Ulrich C.M. .
Source: Nutrition and cancer, 2011; 63(4), p. 558-64.
PMID: 21547848
Related Citations

Linking epidemiology to epigenomics--where are we today?
Authors: Ulrich C.M. , Grady W.M. .
Source: Cancer prevention research (Philadelphia, Pa.), 2010 Dec; 3(12), p. 1505-8.
PMID: 21149325
Related Citations

Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma.
Authors: Poole E.M. , Hsu L. , Xiao L. , Kulmacz R.J. , Carlson C.S. , Rabinovitch P.S. , Makar K.W. , Potter J.D. , Ulrich C.M. .
Source: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2010 Feb; 19(2), p. 547-57.
EPub date: 2010-01-19.
PMID: 20086108
Related Citations

C-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polyps.
Authors: Poole E.M. , Bigler J. , Whitton J. , Sibert J.G. , Potter J.D. , Ulrich C.M. .
Source: Pharmacogenetics and genomics, 2009 Feb; 19(2), p. 113-20.
PMID: 19077918
Related Citations

A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia.
Authors: Cross J.T. , Poole E.M. , Ulrich C.M. .
Source: The pharmacogenomics journal, 2008 Aug; 8(4), p. 237-47.
EPub date: 2008-01-15.
PMID: 18195728
Related Citations

DNA alkylation and DNA methylation: cooperating mechanisms driving the formation of colorectal adenomas and adenocarcinomas?
Authors: Grady W.M. , Ulrich C.M. .
Source: Gut, 2007 Mar; 56(3), p. 318-20.
PMID: 17339242
Related Citations




Back to Top